Jan Bolinder

Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial

Jan Bolinder, Ramiro Antuna, Petronella Geelhoed-Duijvestijn et al. · The Lancet · 2016 · 894 citations

Medicine, Endocrinology, Internal Medicine +14

Effects of Dapagliflozin on Body Weight, Total Fat Mass, and Regional Adipose Tissue Distribution in Patients with Type 2 Diabetes Mellitus with Inadequate Glycemic Control on Metformin

Jan Bolinder, Östen Ljunggren, Joel Kullberg et al. · The Journal of Clinical Endocrinology & Metabolism · 2012 · 860 citations

Medicine, Endocrinology, Pharmacology +17

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections

Marcus Lind, William H. Polonsky, Irl B. Hirsch et al. · JAMA · 2017 · 690 citations

Medicine, Endocrinology, Internal Medicine +17

Improved Glycemic Control in Poorly Controlled Patients with Type 1 Diabetes Using Real-Time Continuous Glucose Monitoring

Dorothee Deiss, Jan Bolinder, Jean-Pierre Riveline et al. · Diabetes Care · 2006 · 544 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial

Tadej Battelino, Ignacio Conget, Birthe Susanne Olsen et al. · Diabetologia · 2012 · 491 citations · Full text

Medicine, Endocrinology, Pediatrics +17